The radioresponsiveness of human tumours and the initial slope of the cell survival curve.
about
A general framework for quantifying the effects of DNA repair inhibitors on radiation sensitivity as a function of doseFully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancersStandards and Methodologies for Characterizing Radiobiological Impact of High-Z Nanoparticles.In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.Radiation therapy for gynecologic cancer.Radiotherapy update.Initial radiation-induced DNA damage in human tumour cell lines: a correlation with intrinsic cellular radiosensitivity.Enhancement of the radiosensitivity of two human tumour cell lines by hexamethylene bisacetamide.Growth and radiosensitivity testing of human tumour cells using the adhesive tumour cell culture system.PLD-repair in human melanoma xenografts following single dose and fractionated irradiation.Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy.DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapyThe potential of proton beam therapy in paediatric cancer.Radiosensitivity and characterisation of a newly established cell line from an epithelioid sarcomaHeterogeneity in radiation sensitivity within human primary tumour cell cultures as detected by the SCE assay.High intrinsic radiosensitivity of a newly established and characterised human embryonal rhabdomyosarcoma cell line.A radiotherapy technique to improve dose homogeneity around bone prosthesesRadiosensitivity of cancer-initiating cells and normal stem cells (or what the Heisenberg uncertainly principle has to do with biology)Radiation therapy for canine appendicular osteosarcoma.Current concepts in clinical radiation oncology.Bringing the heavy: carbon ion therapy in the radiobiological and clinical context.Mean inactivation dose (D). A critical analysis of a neglected parameter in radiotherapy.Can the two mechanisms of tumor cell killing by radiation be exploited for therapeutic gain?The radiobiology of human cells and tissues. In vitro radiosensitivity. The picture has changed in the 1980s.Clinical interest in determinations of cellular radiation sensitivity.Advances in Radiation Therapy in Pediatric Neuro-oncology.Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks.Potential use of the alkaline comet assay as a predictor of bladder tumour response to radiationAssessing and monitoring intratumor heterogeneity in glioblastoma: how far has multimodal imaging come?Radiogenomics and radiotherapy response modeling.The linear-quadratic formula and progress in fractionated radiotherapy.The changing paradigm of tumour response to irradiation.Short-Interval Retreatment With Stereotactic Body Radiotherapy (SBRT) for Pediatric Neuroblastoma Resulting in Severe Myositis.Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis.Current role of radiation therapy for multiple myeloma.Radiosensitivity and capacity for radiation-induced sublethal damage repair of canine transitional cell carcinoma (TCC) cell lines.Radiation biology of malignant melanoma.Radiation oncology in Australia: an increasing crisis.Viability of Non-Coplanar VMAT for Liver SBRT as Compared to Coplanar VMAT and Beam Orientation Optimized 4π IMRT.Tumour hypoxia: the picture has changed in the 1990s.
P2860
Q21245223-6CE9915E-489B-464C-B1E4-99399BE8FD66Q24792155-B630BE21-D91C-42D1-822D-EF28B73C62F2Q26742130-F6B742CA-0949-44B4-B036-3A8C2231CFD8Q30560663-58424C62-C0E9-4EF3-81BC-D4C3FFCC723DQ34819778-A3B4385D-97BD-406B-897F-F73C4BACB471Q35822198-432D4E9D-B0C4-4F00-AE97-CCDAF89377E7Q35978350-91C6349D-59E4-4F01-840F-DFFCB76E0BFFQ35981594-EA3D4E36-C671-4646-9DB1-223D722BD1CAQ35982350-7887F579-46A5-472A-97C0-7404FFB13FDBQ35982637-AD54BB9B-96FD-4E8C-B6AF-A062DC3340D8Q36021361-9BE6105F-A4DC-4DB9-8299-F69AEAF2C125Q36135588-381E10E7-A3D8-41A7-8955-841DF98B5FA0Q36333003-1FC6F9EB-AAAB-43A4-A495-42F19270DCEBQ36466314-FCEAB834-03E6-40A4-8598-7199C78933E3Q36467036-8358A8D8-0510-42BA-9136-A56766A798A6Q36467161-599A44CE-2E6F-47F6-AB99-24604B6645F3Q36674384-8688A309-53BC-483A-9D69-6FE3E0E3AB66Q37237361-145CF9FC-FF8E-46B1-A0A7-31A5A71DD9CDQ37394990-728C586A-C03B-4E04-95E4-5FA6CE6FCEAAQ37603804-11E964B1-B196-4B6C-B9AD-A98A9581C1DEQ37727823-2291907A-E0C2-45B4-8E81-F5DA75038B26Q37904955-04D56B9B-1B99-4DDC-AB4B-8AF105AB5387Q38150778-540F92D4-9F2E-4E0F-8D42-2C24DA955AB3Q38367358-B4D078B3-AB57-4B58-82AF-586411962399Q38367392-7304E145-8848-48A6-B9A8-A4BA29E2E4BBQ38566300-73616828-3591-4CAA-9134-3877C9A681E1Q38602813-5DA03F34-8561-4A27-BD09-4AACB40A6B9AQ38611330-AC65F90A-0B18-4885-85F5-85D2A86F3F5FQ38615302-383C5D10-C68C-47E9-9197-B5CFB4FDE905Q38665620-E23C45B8-6909-4505-9532-D1F69AAF6D8DQ38678064-86F79B1D-F238-400D-B6D0-4A4871C5C047Q38896870-DCCDDC39-AD6D-4E0A-AC20-4DFC17F8C26BQ38916603-E88A1F72-FA47-4841-A6D0-2031ADAFE379Q39006076-61A19580-8D69-43A0-A79D-5CDF90615F13Q39193099-870119E5-F9EF-4CFB-909A-6DC0C0385E58Q39489159-F854FA13-DC6D-4DED-A1CC-8EC775479C26Q39501396-7AF07A3C-7F8F-48D4-B5CC-3F8C29ED6A4EQ39604730-0F475AEF-CA3C-4EF2-AB55-F9AFFD9B31E8Q40285929-E3141CE6-4C4B-4C93-A1B3-5E4C9EC32AAFQ40620931-FD133E51-32A0-4D28-881C-D1E1D8A189D0
P2860
The radioresponsiveness of human tumours and the initial slope of the cell survival curve.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The radioresponsiveness of hum ...... pe of the cell survival curve.
@en
type
label
The radioresponsiveness of hum ...... pe of the cell survival curve.
@en
prefLabel
The radioresponsiveness of hum ...... pe of the cell survival curve.
@en
P2093
P1476
The radioresponsiveness of hum ...... pe of the cell survival curve.
@en
P2093
P304
P356
10.1016/S0167-8140(84)80074-2
P577
1984-12-01T00:00:00Z